Indian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corporate earnings. Ajay Srivastava advises aggressive diversification, favoring legacy and promoter-driven companies, while suggesting caution on Indian IT and highlighting selective opportunities in the export-oriented pharma sector.

Indian stock markets are becoming cautious. Geopolitical tensions and rising crude prices are impacting earnings outlook. Investors are in a 'wait and watch' mode. Higher…

Indian corporate profits are currently strong. However, rising input costs present a significant challenge ahead. Investors should remain patient and selective. Sectors like…